These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 19352081)

  • 1. [Acute myeloid leukemia].
    Watanabe R
    Rinsho Ketsueki; 2009 Mar; 50(3):154-9. PubMed ID: 19352081
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular characterization of acute myeloid leukemia.
    Döhner K; Döhner H
    Haematologica; 2008 Jul; 93(7):976-82. PubMed ID: 18591623
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comprehensive analysis of gene abnormalities in acute myeloid leukemia according to the WHO classification].
    Ishikawa Y
    Rinsho Ketsueki; 2009 Aug; 50(8):597-603. PubMed ID: 19915373
    [No Abstract]   [Full Text] [Related]  

  • 4. Prognostic factors in AML in relation to (ab)normal karyotype.
    Stone RM
    Best Pract Res Clin Haematol; 2009 Dec; 22(4):523-8. PubMed ID: 19959103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prognostic factors of acute myeloid leukemia].
    Inokuchi K
    Nihon Rinsho; 2012 Apr; 70 Suppl 2():389-93. PubMed ID: 23133988
    [No Abstract]   [Full Text] [Related]  

  • 6. Gene expression profiling in AML with normal karyotype can predict mutations for molecular markers and allows novel insights into perturbed biological pathways.
    Kohlmann A; Bullinger L; Thiede C; Schaich M; Schnittger S; Döhner K; Dugas M; Klein HU; Döhner H; Ehninger G; Haferlach T
    Leukemia; 2010 Jun; 24(6):1216-20. PubMed ID: 20428199
    [No Abstract]   [Full Text] [Related]  

  • 7. Adult acute leukemia.
    Cornell RF; Palmer J
    Dis Mon; 2012 Apr; 58(4):219-38. PubMed ID: 22449370
    [No Abstract]   [Full Text] [Related]  

  • 8. Comprehensive analysis of cooperative gene mutations between class I and class II in de novo acute myeloid leukemia.
    Ishikawa Y; Kiyoi H; Tsujimura A; Miyawaki S; Miyazaki Y; Kuriyama K; Tomonaga M; Naoe T
    Eur J Haematol; 2009 Aug; 83(2):90-8. PubMed ID: 19309322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinically useful prognostic factors in acute myeloid leukemia.
    Ferrara F; Palmieri S; Leoni F
    Crit Rev Oncol Hematol; 2008 Jun; 66(3):181-93. PubMed ID: 17996460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and prognosis in acute myeloid leukemia--the art of distinction.
    Löwenberg B
    N Engl J Med; 2008 May; 358(18):1960-2. PubMed ID: 18450608
    [No Abstract]   [Full Text] [Related]  

  • 11. Classification of CEBPA mutated acute myeloid leukemia by GATA2 mutations.
    Marceau-Renaut A; Guihard S; Castaigne S; Dombret H; Preudhomme C; Cheok M
    Am J Hematol; 2015 May; 90(5):E93-4. PubMed ID: 25611491
    [No Abstract]   [Full Text] [Related]  

  • 12. Molecular genetics of adult acute myeloid leukemia: prognostic and therapeutic implications.
    Marcucci G; Haferlach T; Döhner H
    J Clin Oncol; 2011 Feb; 29(5):475-86. PubMed ID: 21220609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing apples and oranges in normal karyotype acute myeloid leukemia.
    Medeiros BC
    J Clin Oncol; 2009 Jan; 27(3):474; author reply 474-6. PubMed ID: 19075259
    [No Abstract]   [Full Text] [Related]  

  • 14. Overall survival in acute myeloid leukaemia patients with and without internal tandem duplication.
    Shahab S; Qadar Z; Nadeem M; Zahid D; Ansari S; Farzana T; Taj M; Borhany M; Ahmed N; Shamsi TS
    Asian Pac J Cancer Prev; 2015; 16(1):393. PubMed ID: 25640387
    [No Abstract]   [Full Text] [Related]  

  • 15. A rapid, one step assay for simultaneous detection of FLT3/ITD and NPM1 mutations in AML with normal cytogenetics.
    Huang Q; Chen W; Gaal KK; Slovak ML; Stein A; Weiss LM
    Br J Haematol; 2008 Jul; 142(3):489-92. PubMed ID: 18477048
    [No Abstract]   [Full Text] [Related]  

  • 16. Minimal residual disease in acute myeloid leukemia: already predicting a safe haven?
    Schuurhuis GJ; Ossenkoppele G
    Expert Rev Hematol; 2010 Feb; 3(1):1-5. PubMed ID: 21082928
    [No Abstract]   [Full Text] [Related]  

  • 17. Acute Myeloid Leukemia Genetics: Risk Stratification and Implications for Therapy.
    Wang ML; Bailey NG
    Arch Pathol Lab Med; 2015 Oct; 139(10):1215-23. PubMed ID: 26414465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Idiopathic hyperammonemia (IHA) after dose-dense induction chemotherapy for acute myeloid leukemia: Case report and review of the literature.
    Metzeler KH; Boeck S; Christ B; Hausmann A; Stemmler HJ; Parhofer KG; Ostermann H; Hiddemann W; Braess J
    Leuk Res; 2009 Jul; 33(7):e69-72. PubMed ID: 19230970
    [No Abstract]   [Full Text] [Related]  

  • 19. Molecular classification of acute myeloid leukemia: are we there yet?
    Radich JP
    J Clin Oncol; 2008 Oct; 26(28):4539-41. PubMed ID: 18559871
    [No Abstract]   [Full Text] [Related]  

  • 20. Acute myeloid leukemia diagnosis in the 21st century.
    Betz BL; Hess JL
    Arch Pathol Lab Med; 2010 Oct; 134(10):1427-33. PubMed ID: 20923295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.